Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRA | P10827 | 3/20 | 0.40 |
| ▸ | THRB | P10828 | 3/20 | 0.40 |
| ▸ | SRC | P12931 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13837398 | 0.92 | THRA (0.45) | THRATHRB | |
| SCHEMBL13837100 | 0.90 | PLA2G2A (0.42) | THRATHRB | |
| SCHEMBL13837298 | 0.85 | THRA (0.40) | THRATHRBSRC | |
| SCHEMBL13837179 | 0.85 | SRC (0.39) | THRATHRBSRC | |
| SCHEMBL13837181 | 0.85 | SRC (0.39) | THRATHRBSRC | |
| SCHEMBL19549634 | 0.85 | SRC (0.39) | THRATHRBSRC | |
| SCHEMBL452254 | 0.85 | THRA (0.40) | THRATHRBSRC | |
| SCHEMBL19549568 | 0.84 | THRA (0.38) | THRATHRBSRC | |
| SCHEMBL13837233 | 0.83 | PLA2G2A (0.55) | THRATHRB | |
| SCHEMBL19549597 | 0.81 | SMPD1 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2711370-B1 | METHOD FOR PRODUCING OLIGONUCLEOTIDES | AJINOMOTO KK (JP) | 2018-01-03 | — | — | EP | claimed |
| US-9790497-B2 | Morpholino oligonucleotide manufacturing method | AJINOMOTO CO., INC. (JP) | 2017-10-17 | — | — | US | claimed |
| EP-3015467-A1 | MORPHOLINO OLIGONUCLEOTIDE MANUFACTURING METHOD | Ajinomoto Co., Inc. (JP) | 2016-05-04 | — | — | EP | claimed |
| US-20160076033-A1 | MORPHOLINO OLIGONUCLEOTIDE MANUFACTURING METHOD | AJINOMOTO CO., INC. (JP) | 2016-03-17 | — | — | US | claimed |
| US-9029528-B2 | Solution-based method of making oligonucleotides via phosphoramidite coupling | AJINOMOTO CO., INC. (JP) | 2015-05-12 | — | — | US | claimed |
| EP-2711370-A1 | METHOD FOR PRODUCING OLIGONUCLEOTIDE | Ajinomoto Co., Inc. (JP) | 2014-03-26 | — | — | EP | claimed |
| US-20120296074-A1 | PRODUCTION METHOD OF OLIGONUCLEOTIDE | AJINOMOTO CO., INC. (JP) | 2012-11-22 | — | — | US | claimed |
| US-20240018180-A1 | OLIGONUCLEOTIDE PRODUCTION METHOD | AJINOMOTO CO., INC. (JP) | 2024-01-18 | — | — | US | disclosed |
| EP-4293035-A1 | OLIGONUCLEOTIDE PRODUCTION METHOD | AJINOMOTO CO., INC. (JP) | 2023-12-20 | — | — | EP | disclosed |
| EP-3950698-A1 | METHOD FOR PRODUCING OLIGONUCLEOTIDE HAVING PHOSPHOROTHIOATE SITE | AJINOMOTO CO., INC. (JP) | 2022-02-09 | — | — | EP | disclosed |
| US-20220010348-A1 | METHOD FOR PRODUCING OLIGONUCLEOTIDE HAVING PHOSPHOROTHIOATED SITE | AJINOMOTO CO., INC. (JP) | 2022-01-13 | — | — | US | disclosed |
| EP-3925964-A1 | PRODUCTION METHOD FOR OLIGONUCLEOTIDES | AJINOMOTO CO., INC. (JP) | 2021-12-22 | — | — | EP | disclosed |
| US-20210371450-A1 | PRODUCTION METHOD FOR OLIGONUCLEOTIDES | AJINOMOTO CO., INC. (JP) | 2021-12-02 | — | — | US | disclosed |
| EP-3208277-A1 | MORPHOLINO OLIGONUCLEOTIDE MANUFACTURING METHOD | AJINOMOTO CO., INC. (JP) | 2017-08-23 | — | — | EP | disclosed |
| US-20170218361-A1 | MORPHOLINO OLIGONUCLEOTIDE MANUFACTURING METHOD | AJINOMOTO CO., INC. (JP) | 2017-08-03 | — | — | US | disclosed |
| EP-3015467-A1 | MORPHOLINO OLIGONUCLEOTIDE MANUFACTURING METHOD | Ajinomoto Co., Inc. (JP) | 2016-05-04 | — | — | EP | disclosed |
| US-20160076033-A1 | MORPHOLINO OLIGONUCLEOTIDE MANUFACTURING METHOD | AJINOMOTO CO., INC. (JP) | 2016-03-17 | — | — | US | disclosed |
| US-9029528-B2 | Solution-based method of making oligonucleotides via phosphoramidite coupling | AJINOMOTO CO., INC. (JP) | 2015-05-12 | — | — | US | disclosed |
| EP-2711370-A1 | METHOD FOR PRODUCING OLIGONUCLEOTIDE | Ajinomoto Co., Inc. (JP) | 2014-03-26 | — | — | EP | disclosed |
| US-20120296074-A1 | PRODUCTION METHOD OF OLIGONUCLEOTIDE | AJINOMOTO CO., INC. (JP) | 2012-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220010348-A1 | METHOD FOR PRODUCING OLIGONUCLEOTIDE HAVING PHOSPHOROTHIOATED SITE | RNGTT, NUDT1, ADAR | THRA 2901/4885THRB 3922/4885SRC 2932/4885 |
| US-20210371450-A1 | PRODUCTION METHOD FOR OLIGONUCLEOTIDES | RNGTT, DCLRE1B, PHOSPHO1 | THRA 2114/4885THRB 2175/4885SRC 4761/4885 |
| US-20120296074-A1 | PRODUCTION METHOD OF OLIGONUCLEOTIDE | RNGTT, POLM, RNMT | THRA 1134/4885THRB 1803/4885SRC 3212/4885 |
| US-20240018180-A1 | OLIGONUCLEOTIDE PRODUCTION METHOD | RNGTT, NOX4, POLRMT | THRA 2919/4885THRB 2294/4885SRC 2152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.